United States: Previewing Generic's Skinny Label: Supreme Court To Rule On Teva's Certiorari Petition - Foley Hoag LLP

United States: Previewing Generic's Skinny Label: Supreme Court To Rule On Teva's Certiorari Petition - Foley Hoag LLP

Mondaq

Published

The Supreme Court is expected to consider Teva's pending petition for certiorari in the highly anticipated GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. on May 11, 2023, a case that could carry enormous implications...

Full Article